Radiation Oncology/Cosmetic Issues

Cosmetic OutcomesEdit

  • Charles T Lee et al. Cancer. 2019. Surgical excision, Mohs micrographic surgery, external-beam radiotherapy, or brachytherapy for indolent skin cancer: An international meta-analysis of 58 studies with 21,000 patients (PMID: 31355928)
    • The objective of this study was to compare the cosmesis and recurrence rates of conventional excision (CE), Mohs micrographic surgery (MMS), external-beam radiation therapy (EBRT), or brachytherapy (BT), for basal cell carcinoma and squamous cell carcinoma of the skin
    • The summary effect size for "good" cosmesis was 81% (95% CI, 70.6%-89.6%), 74.6% (95% CI, 63%-84.6%), and 97.6% (95% CI, 91.3%-100%) for CE, EBRT, and BT, respectively
    • Good cosmesis was 96.0% in the only MMS study that reported cosmesis
    • One-year recurrence rates were low throughout at 0.8% (95% CI, 0.3%-1.6%), 0.2% (95% CI, 0%-0.6%), 2% (95% CI, 1.3%-2.7%), and 0% (95% CI, 0%-0.5%) for CE, MMS, EBRT, and BT, respectively
    • Conclusions (1) For T1-T2N0 skin cancers, BT and MMS have improved cosmesis over EBRT and CE (2) It is unclear whether this is because of treatment superiority or selection and reporting bias (3) Local control is similar among all modalities at 1 year

Radioactive CosmeticsEdit

  • [Article in English, Spanish]

R M Díaz Díaz et al. Actas Dermosifiliogr (Engl Ed). 2020 Dec. Radioactive Cosmetics and Radiant Beauty (PMID: 32402372)

Oncology EstheticsEdit

  • Serena Oliveri et al. Qual Life Res. 2019 Jun. A pilot study on aesthetic treatments performed by qualified aesthetic practitioners: efficacy on health-related quality of life in breast cancer patients (PMID: 30788654)